| pubmed-article:18425995 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18425995 | lifeskim:mentions | umls-concept:C0687725 | lld:lifeskim |
| pubmed-article:18425995 | lifeskim:mentions | umls-concept:C0682161 | lld:lifeskim |
| pubmed-article:18425995 | lifeskim:mentions | umls-concept:C0001948 | lld:lifeskim |
| pubmed-article:18425995 | lifeskim:mentions | umls-concept:C0233401 | lld:lifeskim |
| pubmed-article:18425995 | lifeskim:mentions | umls-concept:C0870371 | lld:lifeskim |
| pubmed-article:18425995 | lifeskim:mentions | umls-concept:C0123091 | lld:lifeskim |
| pubmed-article:18425995 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
| pubmed-article:18425995 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18425995 | pubmed:dateCreated | 2008-6-25 | lld:pubmed |
| pubmed-article:18425995 | pubmed:abstractText | Patients with dual diagnosis are often excluded from clinical trials although more than half of all individuals with Bipolar Disorder have a substance abuse problem at some point in their lifetime, representing a high-risk clinical population. The purpose of this study was to investigate the safety and efficacy of quetiapine in the treatment of alcohol dependence comorbid with disorders characterized by high levels of mood and behavioral instability. | lld:pubmed |
| pubmed-article:18425995 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18425995 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18425995 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18425995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18425995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18425995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18425995 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18425995 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:18425995 | pubmed:issn | 1099-1077 | lld:pubmed |
| pubmed-article:18425995 | pubmed:author | pubmed-author:MartinottiGG | lld:pubmed |
| pubmed-article:18425995 | pubmed:author | pubmed-author:Di NicolaMM | lld:pubmed |
| pubmed-article:18425995 | pubmed:author | pubmed-author:JaniriLL | lld:pubmed |
| pubmed-article:18425995 | pubmed:author | pubmed-author:AndreoliSS | lld:pubmed |
| pubmed-article:18425995 | pubmed:author | pubmed-author:Di... | lld:pubmed |
| pubmed-article:18425995 | pubmed:author | pubmed-author:SarchiaponeMM | lld:pubmed |
| pubmed-article:18425995 | pubmed:copyrightInfo | Copyright 2008 John Wiley & Sons, Ltd. | lld:pubmed |
| pubmed-article:18425995 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18425995 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:18425995 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18425995 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18425995 | pubmed:pagination | 417-24 | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:meshHeading | pubmed-meshheading:18425995... | lld:pubmed |
| pubmed-article:18425995 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18425995 | pubmed:articleTitle | Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. | lld:pubmed |
| pubmed-article:18425995 | pubmed:affiliation | Department of Psychiatry-Addictive Behaviours Unit, Catholic University Medical School, Rome, Italy. giovanni.martinotti@libero.it | lld:pubmed |
| pubmed-article:18425995 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18425995 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18425995 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18425995 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18425995 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18425995 | lld:pubmed |
